How did COVID-19 pandemic restrictions impact invasive meningococcal disease trends?

The impact of COVID-19 pandemic restrictions on the incidence and strain distribution of meningococcus.

Toddlers’ Screen Time Tied to Atypical Sensory Outcomes

Screen time early in life was associated with atypical sensory outcomes, an observational study showed. Children who watched any television or videos at age 12

January 9, 2024

Novo Nordisk, Valo to develop cardiometabolic disease therapies

Novo Nordisk will license three preclinical drug discovery programmes developed using Valo’s platform. Credit: Novo Nordisk. Novo Nordisk has signed an agreement with Valo Health for the

September 26, 2023

CHMP provides positive opinion for BMS’s Reblozyl – Pharmaceutical Technology

Share this article The European Medicines Agency has granted positive opinion to BMS’s Reblozyl, which is forecast to generate $3.17bn in 2029, according to GlobalData.

February 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.